Pneumothorax Ex-vacuo or “trapped lung” in the setting of hepatic hydrothorax
© Kim et al.; licensee BioMed Central Ltd. 2012
Received: 9 May 2012
Accepted: 29 November 2012
Published: 17 December 2012
Hepatic hydrothorax is a major pulmonary complication of liver disease occurring in up to 5-10% of patients with cirrhosis.
We report four observations of the development of pneumothorax ex-vacuo or trapped lung in the setting of hepatic hydrothorax. The diagnosis of trapped lung was made based on the presence of a hydropneumothorax after evacuation of a longstanding hepatic hydrothorax with failure of the lung to re-expand after chest tube placement in three of the four cases. Two patients underwent surgical decortication with one subsequent death from post-operative bleeding. The other two patients remarkably had spontaneous improvement of their “trapped lung” without surgical intervention.
While pneumothorax ex-vacuo is a known phenomenon in malignant effusions, to our knowledge, it has never been described in association with hepatic hydrothoraces. The pathophysiology of this phenomenon remains unclear but could be related to chronic inflammation with development of a fibrous layer along the visceral pleura.
KeywordsHepatohydrothorax Trapped lung Pnumothorax Ex-Vacuo Pleural effusion
Hepatic hydrothorax is a major pulmonary complication of end stage liver disease (ESLD). The diagnosis of hepatic hydrothorax can be made in patients with cirrhosis and portal hypertension who develop large, usually right sided, pleural effusions in the absence of any primary cardiac, pulmonary, or pleural disease. Dysregulation of sodium and fluid management in patients with cirrhosis leads to the development of ascites. The ascites can then migrate from the abdomen to the chest through microperforations in the diaphragm leading to a pleural effusion that is transudative by Light’s criteria. This passage can be further aided by the negative pressure in the chest generated during inspiration. The prevalence of hepatic hydrothorax in the setting of cirrhosis ranges from 5-10% [1–3]. The most cited complications of hepatic hydrothorax include respiratory compromise and spontaneous bacterial pleuritis . Management of hepatic hydrothorax is generally symptomatic. In mild cases, sodium restriction and diuretics can be used to minimize the size of the effusion, supplemented when necessary by therapeutic thoracenteses. In refractory cases, consideration can be given to transjugular intrahepatic porto-systemic shunt (TIPS). In this series, we report four observations of pneumothorax ex-vacuo or trapped lung associated with hepatic hydrothorax.
Pneumothorax ex-vacuo was first described as the result of gas being drawn into the pleural space due to acute endobronchial obstruction with lobar collapse that is fully reversible once the obstruction is resolved . The definition we have adopted for this case series is the one described in inflammatory effusions – when the lung is unable to re-expand after evacuation of pleural fluid that develops after a remote episode of inflammation in the setting of a thickened visceral pleura [6, 7]. To our knowledge, pneumothorax ex-vacuo has never been reported in association with hepatic hydrothoraces.
A 24-year-old male with hepatitis C contracted at birth developed cirrhosis complicated by variceal bleeding, portal hypertension, ascites, and a persistent right-sided hepatic hydrothorax that required thoracenteses every four to six weeks. The effusions were transudative in nature (fluid to serum total protein ratio 0.4, fluid to serum LDH ratio 0.5) and without evidence of infection, pleural, or parenchymal abnormalities consistent with a hepatic hydrothorax. Given his refractory effusions, an indwelling pleural cavity drainage catheter was placed at an outside hospital 8 months prior to his orthotopic liver transplantation (OLT) for self-drainage of the effusion at home. The pleural catheter was removed 1 month after its placement when he was referred for OLT in order to minimize the chance of infectious complications. He was subsequently managed successfully with diuretics and therapeutic thoracenteses as needed for symptomatic relief. At the time of liver transplantation he had undergone approximately ten thoracenteses.
A 68-year old female with non-alcoholic steatohepatitis (NASH) complicated by a refractory right-sided hepatic hydrothorax (fluid to serum total protein ratio 0.3, fluid LDH < 2/3 upper limits of normal serum LDH) presented for an OLT evaluation. The diagnosis of NASH was made 14 years prior and for the 1 year prior to presentation to our hospital, she had required near weekly thoracenteses. The patient was subsequently admitted to our hospital with shortness of breath. Following a therapeutic thoracentesis, she was noted to have a pneumothorax. A 16 French chest tube was placed with no air leak or re-expansion of the lung following chest tube placement. A CT of the chest confirmed the presence of a hydropneumothorax without evidence of endobronchial obstruction. Thoracic surgery was consulted to consider her for definitive management of her pleural effusion because of the persistent high volume drainage (~700 cc per day) from the chest tube. The patient underwent VATS decortication and chemical pleurodesis with resolution of the hydropneumothorax. On POD #20 after her VATS, the patient underwent a successful OLT and did not suffer any further pulmonary or pleural complications.
A 74-year old male with cirrhosis secondary to hepatitis B complicated by a refractory right-sided hepatic hydrothorax (fluid to serum total protein ratio 0.2, fluid LDH < 2/3 upper limits of normal serum LDH) requiring near weekly thoracenteses for the preceding two years presented for an OLT evaluation. After a thoracentesis, he was found to have a pneumothorax and a small bore chest tube was placed by interventional radiology without subsequent re-expansion of the lung. A bronchoscopy was performed and did not reveal any endobronchial abnormalities. Given the complex loculated nature of the effusion, thoracic surgery recommended a thoracotomy with decortication. The operation was complicated by significant post-operative bleeding, and the patient was taken back to the operating room 3 days following the initial thoracotomy due to continued bleeding. Diffuse oozing was found intra-operatively from the parenchymal surface of the lung and the chest wall. The patient suffered a cardiac arrest and expired shortly after surgery.
Clinical characteristics of patients
Previous Indwelling Pleural Catheter (Yes/No)
Y (x 2)
Infection in Pleural Fluid (Yes/No)
# Thoracenteses Performed
Chest Tube (Yes/No)
Surgical Intervention (Yes/No)
Cause of Death
Bleeding after thoracic surgery
Similar to experiences seen with trapped lung in malignant effusions, effective management of trapped lung in the presence of hepatic hydrothoraces remains extremely challenging . Chest tube placement in this setting does not result in lung re-expansion, and surgical intervention can carry significant mortality and morbidity in patients with ESLD due to their underlying coagulopathy. Therefore, the ideal management for pneumothorax ex-vacuo in association with hepatic hydrothorax remains undefined. In our case series, chest tube placement at the initial diagnosis of trapped lung did not result in re-expansion of the lung in any of the patients. Two patients underwent surgical intervention: one patient had a successful outcome, while the other patient died from bleeding complications after thoracic surgery. The latter case underscores the high-risk nature of thoracic surgical intervention in this patient population. Finally, two patients subsequently had spontaneous near-resolution of their trapped lung without further thoracic interventions – one in the setting of immunosuppression after a liver transplant and one prior to liver transplant. The spontaneous improvements in the hydropneumothoraces suggest a potential for pleural remodeling and healing resulting in lung expansion over time, similar to that seen in some patients with trapped lung following an empyema.
To our knowledge, this is the first case series reported of the development of pneumothorax ex-vacuo in association with hepatic hydrothorax. Awareness of this phenomenon is essential in the care and management of patients with ESLD and recurrent hepatic hydrothoraces. In asymptomatic patients with pneumothoraces ex-vacuo in association with hepatic hydrothoraces, observation with conservative management may be appropriate prior to surgical interventions, especially in light of the bleeding complications that can occur with liver disease. It remains unclear whether the development of pneumothorax ex-vacuo would be preventable by keeping the pleural space as dry as possible to minimize chronic inflammation. Additional patients will need to be characterized and followed prospectively to make any further conclusions on the ideal management of this clinical dilemma.
Written informed consent was obtained from the patient or next of kin for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Series Editor of this journal.
YK fellow Pulmonary and Critical Care Program. IS Clinical Professor of Medicine. CL Assistant Clinical Professor, attending physician liver transplant intensive care unit. AZ fellow Liver Transplant Surgery. PE Assistant Clinical Professor, attending liver transplant intensive care unit. MIS Clinical Professor of Medicine. RB Professor, Chairman of UCLA Department of Surgery, Chief of UCLA Liver and Pancreas Transplantation Program, Director of the UCLA Liver Transplant Program. TW Assistant Clinical Professor, Director of Pulmonary Critical Care Consultation Service in the liver transplant intensive care unit.
The work was performed at University of California Los Angeles Medical Center, Los Angeles, California.
End-stage liver disease
Orthotopic liver transplantation
Transjugular intrahepatic porto-systemic shunt
Video-assisted thoracoscopic surgery.
No funding source had any significant role in the preparation, review, or approval of the manuscript.
- Alonso JC: Pleural effusion in liver disease. Semin Respir Crit Care Med. 2010, 31 (6): 698-705. 10.1055/s-0030-1269829.View ArticlePubMed
- Gurung P, Goldblatt M, Huggins JT, Doelken P, Nietert PJ, Sahn SA: Pleural fluid analysis, radiographic, sonographic and echocardiographic characteristics of hepatic hydrothorax. Chest. 2011, 140 (2): 448-453. 10.1378/chest.10-2134. http://www.ncbi.nlm.nih.gov/pubmed?term=%3A%20Pleural%20fluid%20analysis%2C%20radiographic%2C%20sonographic%20and%20echocardiographic%20characteristics%20of%20hepatic%20hydrothorax.#PubMed CentralView ArticlePubMed
- Lazaridis KN, Frank JW, Krowka MJ, Kamath PS: Hepatic hydrothorax: pathogenesis, diagnosis, and management. Am J Med. 1999, 107 (3): 262-267. 10.1016/S0002-9343(99)00217-X.View ArticlePubMed
- Chen CH, Shih CM, Chou JW, Liu YH, Hang LW, Hsia TC, Hsu WH, Tu CY: Outcome predictors of cirrhotic patients with spontaneous bacterial empyema. Liver Int. 2011, 31 (3): 417-424. 10.1111/j.1478-3231.2010.02447.x.View ArticlePubMed
- Berdon WE, Dee GJ, Abramson SJ, Altman RP, Wung JT: Localized pneumothorax adjacent to a collapsed lobe: a sign of bronchial obstruction. Radiology. 1984, 150 (3): 691-694.View ArticlePubMed
- Doelken P, Sahn SA: Trapped lung. Semin Respir Crit Care Med. 2001, 22 (06): 631,636-
- Huggins JT, Sahn SA, Heidecker J, Ravenel JG, Doelken P: Characteristics of trapped lung: pleural fluid analysis, manometry, and air-contrast chest CT. Chest. 2007, 131 (1): 206-213. 10.1378/chest.06-0430.View ArticlePubMed
- Ponrartana S, LaBerge JM, Kerlan RK, Wilson MW, Gordon RL: Management of patients with "Ex vacuo" pneumothorax after Thoracentesis1. Acad Radiol. 2005, 12 (8): 980-986. 10.1016/j.acra.2005.04.013.View ArticlePubMed
- Chang YC, Patz EF, Goodman PC: Pneumothorax after small-bore catheter placement for malignant pleural effusions. Am J Roentgenol. 1996, 166 (5): 1049-1051.View Article
- Efthymiou CA, Masudi T, Charles Thorpe JA, Papagiannopoulos K: Malignant pleural effusion in the presence of trapped lung. Five-year experience of PleurX tunnelled catheters. Interact Cardiovasc Thorac Surg. 2009, 9 (6): 961-964. 10.1510/icvts.2009.211516.View ArticlePubMed
- The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2466/12/78/prepub
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.